The National Institute for Health and Clinical Excellence is recommending an innovative deal for an anti-cancer drug. It says patients with multiple myeloma who show a full or partial response to the drug Velcade should be kept on it and be funded by the NHS.
Those showing a minimal response or no response should be taken off it - with all drug costs refunded by the manufacturer, Janssen-Cilag.
A region’s first specialist children’s hospital – combining physical and mental health services – may be opened in 2023 now the government has approved up to £100m for the long-planned project, the lead chief executive has told HSJ.
The Department of Health and Social Care has confirmed the trusts and partnerships which will receive capital funding worth around £900m for building developments.
More than a dozen NHS trusts in a devolution area have agreed to align their buying power for purchases costing more than £1m, HSJ can reveal.
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay
No comments yet